Identification of distinct clinical phenotypes of cardiogenic shock using machine learning consensus clustering

Li Wang1, Yufeng Zhang2, Renqi Yao3,4,5

  • 1Department of Nephrology, Changzheng Hospital, Naval Medical University, Shanghai, China.

PubMed

Insights

Machine learning identified two distinct cardiogenic shock (CS) phenotypes. One phenotype shows better outcomes, aiding in personalized treatment strategies for CS patients.

Area of Science:

  • Critical Care Medicine
  • Data Science in Healthcare
  • Cardiology

Background:

  • Cardiogenic shock (CS) presents complex challenges due to diverse causes and outcomes.
  • Differentiating between various CS phenotypes remains clinically difficult.
  • Identifying distinct CS phenotypes is crucial for targeted interventions and improved patient prognoses.

Purpose of the Study:

  • To investigate the utility of machine learning (ML) consensus clustering for identifying distinct cardiogenic shock (CS) phenotypes.
  • To explore if these identified phenotypes possess unique clinical profiles and prognoses.
  • To leverage ML for a data-driven approach to CS classification.

Main Methods:

  • Utilized unsupervised ML consensus clustering on a large cohort of 21,925 patients with CS from the eICU Collaborative Research Database.
  • Determined the optimal number of clusters using consensus matrix heatmap, CDF, cluster-consensus plots, and PAC analysis.
  • Analyzed key features differentiating clusters using standardized mean difference and logistic regression for clinical endpoint associations.

Main Results:

  • Identified two distinct CS clusters (Cluster 1: 9,848 patients; Cluster 2: 12,077 patients).
  • Cluster 1 exhibited lower blood pressure, poorer renal function (lower eGFR, higher BUN/creatinine), and higher severity scores (SOFA, APS III, APACHE IV).
  • Cluster 2 was significantly associated with lower in-hospital mortality (OR 0.374), ICU mortality (OR 0.349), and reduced incidence of acute kidney injury (AKI) (OR 0.478).

Conclusions:

  • ML consensus clustering effectively synthesizes clinical and laboratory data to reveal distinct CS phenotypes.
  • The identified phenotypes possess significantly different clinical profiles and prognoses.
  • This approach offers a promising avenue for stratifying CS patients and guiding clinical decision-making.
Abstract

Related Concept Videos

Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
19
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
15
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
810
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
19
Heart Failure III: Clinical Manifestations01:26

Heart Failure III: Clinical Manifestations

Heart failure (HF) manifests primarily as dyspnea, fatigue, and fluid retention, resulting in peripheral and pulmonary edema. Symptoms may vary depending on which ventricle is more affected, left or right.Left-Sided Heart FailureAlso known as left ventricular failure, this condition results from the left ventricle's inability to fill or eject sufficient blood into the systemic circulation. It leads to pulmonary congestion, which occurs when the left ventricle fails to eject blood effectively...
23